Apex Biotechnology Corp. (TPE:1733)
Taiwan · Delayed Price · Currency is TWD 28.95
-0.95 (-3.18%)
Mar 4, 2026, 11:45 AM CST
Apex Biotechnology Market Cap
Apex Biotechnology has a market cap or net worth of 2.99 billion as of March 3, 2026. Its market cap has decreased by -4.47% in one year.
Market Cap
2.99B
Enterprise Value
2.54B
Revenue
1.96B
Ranking
n/a
PE Ratio
19.94
Stock Price
28.95
Market Cap Chart
Since September 7, 2001, Apex Biotechnology's market cap has increased from 1.43B to 2.99B, an increase of 109.72%. That is a compound annual growth rate of 3.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 3.00B | -1.31% |
| Dec 31, 2025 | 3.04B | 1.16% |
| Dec 31, 2024 | 3.01B | -25.31% |
| Dec 29, 2023 | 4.03B | 57.73% |
| Dec 30, 2022 | 2.55B | -1.73% |
| Dec 30, 2021 | 2.60B | 10.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genovate Biotechnology | 3.61B |
| Sagittarius Life Science | 3.50B |
| Shine-On BioMedical | 3.29B |
| SYN-TECH Chem. & Pharm. | 3.27B |
| Syngen Biotech | 3.25B |
| 3D Global Biotech | 3.14B |
| GlycoNex Incorporation | 2.84B |
| Sunny Pharmtech | 2.75B |